miR-101 Acts as a Tumor Suppressor by Targeting Kruppel-like Factor 6 in Glioblastoma Stem Cells.

CONCLUSIONS: Our findings provided a comprehensive analysis of miR-101 and further defining it as a potential therapeutic candidate for GBM.
PMID: 25230316 [PubMed - as supplied by publisher]

Source: CNS Neuroscience and Therapeutics - September 17, 2014 Category: Neuroscience Authors: Yao YL, Ma J, Wang P, Xue YX, Li Z, Zhao LN, Li ZQ, Feng TD, Liu YH Tags: CNS Neurosci Ther Source Type: research